Literature DB >> 10026858

Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene.

P F Searle1, S J Weedon, I A McNeish, M G Gilligan, M J Ford, F Friedlos, C J Springer, L S Young, D J Kerr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10026858     DOI： 10.1007/978-1-4615-5357-1_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  2 in total

Review 1.  Modifications of human carboxylesterase for improved prodrug activation.

Authors:  Jason M Hatfield; Monika Wierdl; Randy M Wadkins; Philip M Potter
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-09       Impact factor: 4.481

2.  Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle-directed enzyme prodrug therapy as a novel approach to cancer treatment.

Authors:  Patrick Ball; Jennifer Halliwell; Simon Anderson; Vanessa Gwenin; Christopher Gwenin
Journal:  Microbiologyopen       Date:  2020-09-26       Impact factor: 3.139
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.